Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030032
Filing Date
2019-08-07
Accepted
2019-08-07 16:02:11
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20190630.htm 10-Q 1781843
2 EX-3.2 scyx-ex32_42.htm EX-3.2 7420
3 EX-10.1 scyx-ex101_104.htm EX-10.1 182395
4 EX-31.1 scyx-ex311_8.htm EX-31.1 15629
5 EX-31.2 scyx-ex312_7.htm EX-31.2 15594
6 EX-32.1 scyx-ex321_9.htm EX-32.1 9417
  Complete submission text file 0001564590-19-030032.txt   8470468

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT scyx-20190630.xml EX-101.INS 2306137
8 XBRL TAXONOMY EXTENSION SCHEMA scyx-20190630.xsd EX-101.SCH 44078
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20190630_cal.xml EX-101.CAL 50729
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20190630_def.xml EX-101.DEF 153049
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20190630_lab.xml EX-101.LAB 403190
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20190630_pre.xml EX-101.PRE 314329
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 191005386
SIC: 2834 Pharmaceutical Preparations